Virax Biolabs Group Ltd (NASDAQ:VRAX) currently has a daily average trading volume of 4.59M but it saw 1717425 shares traded in last market. With a market cap of 8.03M USD, the company’s current market price of $1.85 came rising about 14.20 while comparing to the previous closing price of $1.62. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.00 and as low as $0.60. In the recent trading on the day, stock has struck highest price mark of $1.5304 while lowest mark touched by it was $2.1691.
Taking a look at 20-day trading activity of Virax Biolabs Group Ltd (VRAX) gives us an average price of $2.5370, while its current price level is -79.44% below from 52-week high level whereas it is 208.33% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.6417 while that of 200 days or SMA-200 reads an average of $1.4230. A closer look into the stock’s movement over the week reveals that its volatility is standing at 17.25% during that period while stretching the period over a month that decreases to 14.80%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 38.85 which implies that the stock is in neutral territory.
Over the week, VRAX’s stock price is moving -7.04% down while it is -59.34% when we observe its performance for the past one month. Year-to-date it is 26.71% up and over the past year, the stock is showing a downside performance of -43.94%.
Currently, Virax Biolabs Group Ltd’s total number of outstanding shares is 4.34M. Company’s return on investment (ROI) stands at -121.48% and return on equity (ROE) at -92.92%. Stock’s beta reads 2.02. Stock has a price to book (P/B) ratio of 0.89 while price to sale or P/S ratio amounts to 50.18. Its return on asset (ROA) is -88.04% on average.
